EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives

Roland E Schmieder

Nephrology Dialysis Transplantation · 2023

DOI: 10.1093/ndt/gfac189 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2023. Verfasst von Roland E Schmieder. Beteiligte Einrichtung: Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Hypertension. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Medtronic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Supported by several high-quality randomized controlled trials and registry analyses, catheter-based renal denervation is becoming an important adjunctive treatment modality for the safe and efficacious treatment of hypertension besides lifestyle modifications and antihypertensive medication. Renal denervation is of particular interest to nephrologists as the intervention may provide additional benefits to hypertensive people with chronic kidney disease (CKD), a condition typically characterized by sympathetic hyperactivity. A growing body of clinical evidence supports the safety and efficacy of renal denervation in this difficult-to-control population. In addition, preclinical and clinical research works indicate potential nephroprotective effects in CKD patients. The current review examines recent research on renal denervation with a focus on renal disease and assesses the latest findings and their implications from a nephrologist's perspective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicHypertensionHumansKidneyAntihypertensive AgentsTreatment OutcomeDenervationSympathectomyBlood Pressure

Stichwörter der Autor:innen

chronic kidney diseasehypertensionnephroprotectionrenal denervationsympathetic hyperactivity

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany.

Förderung

  • Medtronic

Zitieren

APA

Schmieder, R. E. (2023). Renal denervation in patients with chronic kidney disease: current evidence and future perspectives. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfac189

Vancouver

Schmieder RE. Renal denervation in patients with chronic kidney disease: current evidence and future perspectives. Nephrology Dialysis Transplantation. 2023. doi:10.1093/ndt/gfac189

BibTeX
@article{Schmieder2023,
  author = {Schmieder, Roland E},
  title = {Renal denervation in patients with chronic kidney disease: current evidence and future perspectives},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  doi = {10.1093/ndt/gfac189}
}
Kostenlos starten →